Total serum bile acids were estimated by an enzymic (3a-hydroxysteroid dehydrogenase)method in 173 fasting patients with different liver diseases, classified Into 17 groups by morphological criteria. The results were not highly correlated with those for any of the other 24 tests included In the study, but moderate correiations were observed with bilirubin or alanine aminotransferase (positive) and with preaibumin (negative) In a few patientgroups. We determined serum bile acids by an enzymic method (9) in patients with liver disease, classified mainly by morphological criteria, to evaluate whether this test in fact adds information to a panel of 24 other "liver tests."
Methods
The tests listed in Tables 4 and 5 were performed according to methods and programs for standardization and quality control as described previously (10, 11, 13, 14).
Enzymatic Determination of Total Bile Acids In Serum
Reagents (the kit "Sterognost-3a Automated") were purchased from Nyegaard & Co. A/S, Oslo, Norway. The method utilizes 3a-hydroxy-steroid:NAD(P) oxidoreductase (3cr-HSD; EC 1.1.1.50) from Pseudomonas testosteroni grown on a steroid-containing medium, and was introduced by Mashige et al. (9) . It is based upon the conversion of 3cr-OH bile acids to 3cr-keto species by 3a-HSD in the presence of NAD. The reducing equivalents of the NADH produced are transferred to resazurine by a diaphorase, with resorufme (a fluorophore) as the product. We measured the fluorescence at 580 nm with a Packard spectrofluorometer, with an excitation wavelength of 565 nm. As standard we used sodium taurocholate. The procedure recommended by the manufacturer, slightly modified, yielded linear standard curves. The "blank" reagent was not used. Instead we used as a blank the test reagent plus 0.2 mmol/liter of parachloromercuribenzoate (which inhibits 3a-HSD completely) and serum, treated exactly as the test samples. This was done to correct for fluorescence not derived from the final product (resorufine), particularly since the stability of the resa.zurmne during storage was different in the test kit and the blank kit. By the present method, primary as well as secondary bile acids (conjugated and unconjugated) are measured. Bile acids sulfated at the C3-position are not estimated. They may occur in cholestatic syndromes, but even then very infrequently constitute as much as 10-20% (15, 16) of the total bile acids.
The precision of the method at a concentration of bile acids in serum of about 30 imol/liter was 9.1%, as expressed by the coefficient of variation.
Reference Range for Serum Bile Acids
Thirty-six women and 51 men, ages 20-29 years, all "healthy" and fasting overnight, were selected from a larger reference group described previously (12). These sera were also stored at -70 #{176}C for about five years. The mean concentration (SD) found by our method was 4 
Statistical Methods
Computer programs for discriminant analysis developed by H. E. Solberg have been described previously (11). Optimum combinations of tests were identified by the best-ofall-possible-combinations method (17) when not otherwise indicated.
The correlations between different tests were analyzed by the nonparametric method, Spearman's rank-correlation test (18). Table 1 shows that the bile acid concentrations in serum were above normal in all patient groups. Within each of the present groups the vlues were scattered over a wide range, and the overlapping between different types of liver disease was considerable. The highest values for serum bile acids were seen in cases of acute viral hepatitis and in primary biliary cirrhosis, but even in chronic persistent hepatitis-when other liver tests are often normal-most results were increased and the mean was five times that of the reference group. For comparison, Table 1 also shows some other "liver tests" thought to reflect cell injury, cholestasis, or capacity for protein synthesis. Table 2 shows the correlation between serum bile acids and some other commonly used "liver tests" within some of the present group and in the pooled patient material. The correlation was highest with bilirubin, but was not high with any of the tests in any group. Next to bilirubin, alanine aminotransferase showed the highest positive correlation with bile acids. Most of the patients with liver disease had above-normal values for bile acids.
Results
In acute hepatitis as well as in the pooled patient material, bile acids were negatively correlated with prealbumin, which is considered to reflect the capacity for synthesis of plasma proteins (10, 19-21). Bile acids were not positively correlated to alkaline phosphatases in primary biliary cirrhosis, and not to ceruloplasmin in any group or in the pooled material, although the latter parameter is usually increased in cholestasis (10, 11). Table 3 shows a comparison of the sensitivity (percentage of abnormal results, considering results above the upper reference limit as abnormal) of the test for bile acids in serum from fasting persons with that of some serum enzymes, prealbumin, and total bilirubin. Bile acids had generally the same sensitivity as the aminotransferases-even slightly more sensitive in cirrhosis. They were more sensitive than prealbumin [and other plasma protein included in this study (10)) and total bilirubin. Table 4 shows the contribution of the bile acid test to the separation of the active chronic hepatitis and primary biliary cirrhosis groups. The 20 best combinations of four tests among 22 tests (first column) were identified by discriminant analysis using the best-of-all-possible-combinations method (11, 17). By the best subset of four tests chosen, correct reclassification was obtained in 95% of the patients.
Serum ceruloplasmin, which is usually increased in the cholestasis that characterizes primary biiary cirrhosis, was included in all of the 20 best four-test combinations. Bile acids were included in nine test-combinations when ceruloplasmin was included in the run. When the discriminant analysis was repeated without this protein (second column) bile acids were chosen in all 20 combinations. Also aspartate aminotransferases and phospholipids then appeared in almost all the best test combinations. Subsequent runs without parameters of cholestasis [ceruloplasmin, phospholipids, and coagulation factors (Normotest kit)] showed that most information on cholestasis was then apparently carried by alkaline phosphatases and total cholesterol (columns 3 and 4). When bile acids were removed from the list of tests (fifth column), cholesterol was reduced to only three combinations, but alkaline phosphatases appeared in all combinations. In uncited runs with stepwise discriminant analysis (17), bile acids did not improve the separation obtained previously (11) between the following pairs of groups: acute viral hepatitis and chronic persistent hepatitis; active chronic hepatitis and chronic persistent hepatitis; and alcoholic cirrhosis and alcoholic steatosis. Table 5 shows the contribution of bile acids to the six best four-test combinations for discrimination among five chronic liver diseases. The inclusion of bile acids among the tests in the present study improved reclassification to 68% from 64% (11). Bile acid test was included in four out of the 20 best test combinations. This frequency was the fifth among the tests. Ceruloplasmin was present in all 20 combinations.
Discussion
Our enzymic method for the determination of bile acids requires a spectrofluorometer, but is easily performed in series and has an acceptable precision. The specificity of the 3a-hydroxysteroid dehydrogenase is high (6) and the analytical recovery of added bile acids is good (6), although the accuracy of this and other methods has to be documented by "absolute" methods such as mass fragmentography. The present method does not include C3-sulfated bile acids, but these usually constitute less than 5% of serum total bile acids, even in cholestasis (15, 16 
7, 8, 22, 23).
Our study confirms and extends the conclusion of previous reports (7, 22) that the concentration of total bile acids in fasting patients is not highly correlated with other "liver tests," but is correlated to a certain extent with total bilirubin. As in previous studies (1,4, 7,8, 22,23) we found the estimation of fasting serum bile acids to be a more sensitive liver test than is total bilirubin. In cirrhotics, the test may even be more sensitive than aminotransferases and other serum enzymes.
Using discriminant analysis, we found that the fasting bile acid test sometimes added information to a panel of 24 tests examined previously (11). As was to be expected from the physiology and pathophysiology (24) of bile acids, the type of information carried by this test (as by bilirubin) is probably rather mixed. Different parenchymal disorders and cholestatic syndromes will affect composition, concentration, and kinetics of the bile acids in the blood. Accordingly, we found that the total serum bile acids were sometimes moderately correlated with tests thought to express quite different "liver functions." Thus, in acute hepatitis, bile acids were negatively correlated with prealbumin, which may reflect reduced capacity for synthesis functions. In this group, it was positively correlated with alanine aminotransferase, which is not a test of function but probably indicates cellular injury ("leakage").
We often found that test combinations with bile acids also included aminotransferases and indexes of cholestasis (e.g., phospholipids). Probably these tests reflect cellular injury or cholestasis better than do bile acids. Bile acids may, however, carry additional information even on cholestasis, since alkaline phosphatases appeared more frequently in the subsets when bile acids were removed from the list of analyses.
In conclusion, we found total 3a-hydroxy bile acids in serum to be easily estimated by the present enzymic method. The test is a rather sensitive indicator of liver dysfunction, and it is specific for liver disease. When attempting to separate groups of liver disease by discriminant analysis, we also found the serum bile acids added some new information the panel of tests used previously (11) .
